Are we there yet? Vaccination success won’t ease need for LTC vigilance, observers say
By
Alicia Lasek
Feb 18, 2021
The need for stepped-up infection control measures likely will remain a necessity for the foreseeable future, say industry observers and stakeholders.
Vaccinations tied to drop in nursing home infections; states want greater role in pharmacy allocations
By
Alicia Lasek
Feb 17, 2021
Nursing homes experienced a 48% decline in new resident cases three weeks after their first onsite vaccine clinic. That’s compared with a 21% decline among unvaccinated nursing homes located in the...
Healthcare workers less hesitant to receive COVID-19 vaccination, survey finds
By
Alicia Lasek
Feb 17, 2021
Fewer healthcare workers say they’ll refuse a COVID-19 shot now than they did in December, investigators have found. And hesitant respondents explained what might change their minds.
Factor in chills, lesser-known symptoms to better detect COVID-19, study shows
By
Alicia Lasek
Feb 16, 2021
Factoring four overlooked COVID-19 symptoms into testing efforts significantly improves detection, investigators say.
COVID-19 mortality tied to racial disparities in nursing homes, industry expert says
By
Alicia Lasek
Feb 11, 2021
Nursing homes with a non-white resident population of more than 40% have more than three times the rate of COVID-19 cases and deaths than those with fewer non-white residents, says R. Tamara Konetzka,...
What happens once Phase 1 vaccine clinics wrap up? Ensuring access to next doses
By
Kimberly Bonvissuto
Alicia Lasek
Feb 10, 2021
Industry advocates and the CDC answer key questions: How to facilitate a smooth transition to a new vaccine supplier; and how to guarantee second doses for staff and residents who receive their first dose...
CDC: Vaccine hesitancy falls in priority groups, but only half of adults under 65 willing
By
Alicia Lasek
Feb 10, 2021
The most recent agency data show an increase in the number of willing vaccine recipients among groups prioritized for vaccination. Messages from clinicians could further boost confidence, investigators...
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Past bout with pneumonia a strong predictor of COVID-19 severity: study
By
Alicia Lasek
Feb 08, 2021
A history of pneumonia is one of the most important risk factors for predicting COVID-19 mortality in older adults, a Harvard analysis of EHR data has found.
Six-year study links hearing loss to dementia risk
By
Alicia Lasek
Feb 04, 2021
A study of older Australians has revealed a strong link between self-reported hearing loss and cognition, along with increased risk for mild cognitive impairment or dementia.